Aldagen

Regenerative cell therapies for vascular disorders

placeDurham, North Carolina, United States calendar_todayFounded 2001 groups18 employees language aldagen.com

Registered entities

Innovation

3 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 93 times.

YearFilings
20121
20151

Investor mix

11 investors on record; lead investors include Harbert Management, Intersouth Partners; 2 have since exited.

Investor typeCountShare
Venture capital655%
Private equity218%
Angel & family office218%
Other / undisclosed19%
Coming soon